Aaron Osborne
Keine laufenden Positionen mehr
Profil
Aaron Osborne worked as a Principal Director-Medical at Genentech, Inc. from 2018 to 2019.
Prior to that, he was the Head-Global Medical Affairs at Alcon Research Ltd.
from 2013 to 2015 and at Novartis Pharma AG from 2012 to 2013.
He also served as the Chief Medical Officer at Adverum Biotechnologies, Inc. from 2019 to 2021.
Dr. Osborne earned a doctorate degree from University College London in 1998.
Ehemalige bekannte Positionen von Aaron Osborne
| Unternehmen | Position | Ende |
|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 17.03.2021 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.03.2019 |
Alcon Research Ltd.
 Alcon Research Ltd. Medical SpecialtiesHealth Technology Part of Nestlé SA, Alcon Research Ltd. is a leader in innovative eye care, offering surgical and vision care solutions. The company is based in Huntington, WV. The company transforms eye care possibilities into realities through the discovery and development of its innovative eye care products and solutions. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2015 |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2013 |
Ausbildung von Aaron Osborne
| University College London | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Alcon Research Ltd.
Alcon Research Ltd. Medical SpecialtiesHealth Technology Part of Nestlé SA, Alcon Research Ltd. is a leader in innovative eye care, offering surgical and vision care solutions. The company is based in Huntington, WV. The company transforms eye care possibilities into realities through the discovery and development of its innovative eye care products and solutions. | Health Technology |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
